diethyl (((2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-((benzyloxy)methyl)-3-((tert-butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methyl)phosphonate | 172223-08-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: diethyl (((2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-((benzyloxy)methyl)-3-((tert-butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methyl)phosphonate
• 英文别名: diethyl C-(2-O-(tert-butyldimethylsilyl)-3,4,6-tri-O-benzyl-α-D-glucopyranosyl)methanephosphonate；diethyl C-(2-O-tertbutyldimethylsilyl-3,4,6-tri-O-benzyl-α-D-glucopyranosyl)methanephosphonate；tert-butyl-[(2S,3R,4S,5R,6R)-2-(diethoxyphosphorylmethyl)-4,5-bis(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-3-yl]oxy-dimethylsilane
• CAS: 172223-08-4
• 化学式: C₃₈H₅₅O₈PSi
• 分子量: 698.909
• InChiKey: UPXNBWIOGDVNLP-KNUMEIEKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.8
• 重原子数：
  48
• 可旋转键数：
  19
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  81.7
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  diethyl (((2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-((benzyloxy)methyl)-3-((tert-butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methyl)phosphonate 在 4-二甲氨基吡啶 、 盐酸羟胺 、 水 、 乙酸酐 、 溶剂黄146 、 二甲基亚砜 、 三氟乙酸 、 diborane(6) 作用下， 以 四氢呋喃 、 吡啶 、 甲醇 、 二氯甲烷 为溶剂， 反应 2.0h， 生成 ((2S,3R,4R,5S,6R)-3-Amino-4,5-bis-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-ylmethyl)-phosphonic acid diethyl ester
  参考文献：
  名称：

  Stereoselective Synthesis of the Isosteric Phosphono Analogues of N-Acetyl-α-d-glucosamine 1-Phosphate and N-Acetyl-α-d-mannosamine 1-Phosphate

  摘要：

  The isosteric phosphono analogues of N-acetyl-alpha-D-glucosamine I-phosphate and N-acetyl-alpha-D-mannosamine l-phosphate (1 and 2) are stereoselectively synthesized starting from 2,3,5-tri-O-benzyl-D-arabinose (3b). Reaction of 3b with divinylzinc stereoselectively affords the glucoenitol 4c, the mercuriocyclization and subsequent iododemercuriation of which stereoselectively afford the alpha-C-glucopyranosyl iodide 6b with a free hydroxyl group at C-2. Temporary protection of the hydroxyl group and treatment with triethyl phosphite converts 6b into the corresponding phosphonate 7b. The free hydroxyl group of 7b is then converted into an acetamido group by oximation, acetylation of the oxime, reduction, and subsequent acetylation. The reduction of the oxime with diborane stereoselectively affords the gluco isomer, whereas catalytic hydrogenation gives the manno isomer. Acetylation and deprotection afford the desired products 1 and 2.

  DOI：

  10.1021/jo9519468
• 作为产物：
  描述：

  (2S,3R,4R,5R,6R)-4,5-bis(benzyloxy)-6-((benzyloxy)methyl)-2-(iodomethyl)tetrahydro-2H-pyran-3-ol 在 咪唑 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 diethyl (((2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-((benzyloxy)methyl)-3-((tert-butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methyl)phosphonate
  参考文献：
  名称：

  Stereoselective Synthesis of the Isosteric Phosphono Analogues of N-Acetyl-α-d-glucosamine 1-Phosphate and N-Acetyl-α-d-mannosamine 1-Phosphate

  摘要：

  The isosteric phosphono analogues of N-acetyl-alpha-D-glucosamine I-phosphate and N-acetyl-alpha-D-mannosamine l-phosphate (1 and 2) are stereoselectively synthesized starting from 2,3,5-tri-O-benzyl-D-arabinose (3b). Reaction of 3b with divinylzinc stereoselectively affords the glucoenitol 4c, the mercuriocyclization and subsequent iododemercuriation of which stereoselectively afford the alpha-C-glucopyranosyl iodide 6b with a free hydroxyl group at C-2. Temporary protection of the hydroxyl group and treatment with triethyl phosphite converts 6b into the corresponding phosphonate 7b. The free hydroxyl group of 7b is then converted into an acetamido group by oximation, acetylation of the oxime, reduction, and subsequent acetylation. The reduction of the oxime with diborane stereoselectively affords the gluco isomer, whereas catalytic hydrogenation gives the manno isomer. Acetylation and deprotection afford the desired products 1 and 2.

  DOI：

  10.1021/jo9519468

文献信息

• Synthesis of stable C-phosphonate analogues of Neisseria meningitidis group A capsular polysaccharide structures using modified Mitsunobu reaction conditions
  作者：Peter Teodorović、Rikard Slättegård、Stefan Oscarson

  DOI：10.1039/b614038f

  日期：——

  Examples of synthetic C-phosphonate analogues of microbial polysaccharide structures containing inter-residue phosphodiester linkages are most rare. The successful construction of such analogues of the Neisseria meningitidis Group A capsular polysaccharide is described. Using a modified Mitsunobu reaction (tris(4-chlorophenyl)phosphine, DIAD, excess of Et3N) between an anomeric C-phosphonate monoester

  含有残基间磷酸二酯键的微生物多糖结构的合成C-膦酸酯类似物的例子是最罕见的。描述了脑膜炎奈瑟氏球菌A类荚膜多糖的此类类似物的成功构建。使用异头C-膦酸酯单酯和6-OH ManNAc受体之间的修饰的Mitsunobu反应（三（4-氯苯基）膦，DIAD，过量的Et3N），可获得高产率（88％）的二聚体。通过脱乙酰基将二聚体转化为新的6-OH受体，并在相同条件下与延伸的C-膦酸酯单体进一步反应，以92％的收率得到三聚体。然后重复该过程，得到四聚体，其偶联产率为85％。那个
• First synthesis of the phosphono analogue of N-acetyl-α-<scp>D</scp>-mannosamine 1-phosphate
  作者：Laura Cipolla、Luigi Lay、Francesco Nicotra、Luigi Panza、Giovanni Russo

  DOI：10.1039/c39950001993

  日期：——

  treatment of the iodide with triethylphosphite to afford the corresponding phosphonate, deprotection of the hydroxy group, oxidation, oximation, catalytic hydrogenation and acetylation, afford the phosphono analogue of N-acetyl-α-D-mannosamine 1-phosphate.

  用二乙烯基锌对2,3,5-三-O-苄基-D-阿拉伯糖进行构图，随后进行巯基环化和碘脱汞立体选择性，得到α-C-吡喃葡萄糖基碘化物3，在C-2处具有游离羟基。暂时保护游离羟基，用亚磷酸三乙酯处理碘化物得到相应的膦酸酯，羟基去保护，氧化，肟化，催化氢化和乙酰化，得到N-乙酰基-α - D-甘露糖胺的膦酰基类似物1 -磷酸盐。
• Carbohydrate Phosphonate Derivatives as Modulators of Glycosylation
  申请人：AMGEN INC.

  公开号：US20150376221A1

  公开（公告）日：2015-12-31

  Compounds of Formula (I) are useful as modulators of glycosylation. Compounds of Formula (I) have the following structure: (I) and the definitions of the other variables are provided herein.

  化合物I的公式对糖基化的调节剂非常有用。化合物I的结构如下：(I)，其他变量的定义在此提供。
• Carbohydrate phosphonate derivatives as modulators of glycosylation
  申请人：AMGEN INC.

  公开号：US09328134B2

  公开（公告）日：2016-05-03

  Compounds of Formula (I) are useful as modulators of glycosylation. Compounds of Formula (I) have the following structure: (I) and the definitions of the other variables are provided herein.

  公式（I）的化合物可用作糖基化调节剂。公式（I）的化合物具有以下结构：（I），其他变量的定义在此提供。
• WO2006/120576
  申请人：——

  公开号：——

  公开（公告）日：——